Scientists; have developed a proprietary platform that uses artificial intelligence-based video games to diagnose, track and treat patients with depression. It was stated that the games on the platform are based on the discipline of neuropsychology.
UK-based mental health company; has developed a proprietary platform that uses artificial intelligence-based video games to diagnose, track and treat patients with depression. It was stated that the games on the platform are based on the discipline of neuropsychology. It was stated that the games analyze the micro facial expressions and speech patterns of the patients to assess their mental health.
According to the news, Aksam.com.tr quoted pointed out that methods currently used to assess mental health problems such as depression and anxiety are dubious and rely on subjective questionnaires that tend to yield biased results. It was also underlined that clinicians complained about spending more time on administrative tasks instead of on their patients.
CEO and co-founder Dr. Emilia in an official statement, stated that the current system is flawed in many ways, GPs do not have enough time and there is no tracking system between patient appointments. Also added is the first system to offer objectivity and use a variety of data types to create an accurate and robust depression model.
THE PLATFORM CREATES A PERSONALIZED REPORT BASED ON THE DATA
According to other shared information; Thyme has developed a video game-based mental health monitoring system that aims to assist patients and clinicians in targeting current depression treatment problems. It was stated that patients who log into the platform will be able to engage in fun activities and video pg slot games. The system; in this way, it was stated that it could determine the probability of depression, evaluate the potential severity of depression and create a personalized report about the users.
According to the transferred details, the platform; uses neuropsychological games to collect data on users’ cognitive behaviors such as error rate, reaction time, and memory in games. Also uses anonymized data of users’ faces to detect signs of depression. However, voice data is also collected over conversations to detect signs of depression.
CLINICAL EXPERIMENTS ON THE SYSTEM WILL BE STARTED IN 2022
If a patient is determined to need clinical assistance, when the patient visits the clinician, the specialist can benefit from the data collected and diagnose the patient through it. Patients can access games and activities on the platform to monitor their behavioral changes during their treatment period. Thus, the clinician can evaluate changes in the patient and understand whether the treatment is working.
It is stated that the company collects user data from over 2,000 depressed patients and healthy to train artificial intelligence models on the platform. However, experts point out that they are not yet sure whether the system will have the expected effect on patients. It is stated that clinical trials of the system will begin this year.